Zivo Bioscience Inc (OTCMKTS:ZIVO) Director Christopher D. Maggiore purchased 116,000 shares of Zivo Bioscience stock in a transaction on Thursday, March 8th. The shares were acquired at an average cost of $0.11 per share, with a total value of $12,760.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Zivo Bioscience Inc (ZIVO) traded down $0.00 during trading hours on Monday, hitting $0.12. 33,100 shares of the stock traded hands, compared to its average volume of 191,564. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of -0.98. Zivo Bioscience Inc has a 52-week low of $0.05 and a 52-week high of $0.15.
TRADEMARK VIOLATION WARNING: “Zivo Bioscience Inc (ZIVO) Director Buys $12,760.00 in Stock” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/03/12/zivo-bioscience-inc-zivo-director-buys-12760-00-in-stock.html.
Zivo Bioscience, Inc, formerly Health Enhancement Products, Inc, is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients.
Receive News & Ratings for Zivo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zivo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.